Caruana Giorgia, Bertozzi Nicolò, Boschi Elena, Pio Grieco Michele, Grignaffini Eugenio, Raposio Edoardo
Ann Ital Chir. 2015 Jan-Feb;86(1):1-4.
Adipose tissue represent an alternative source of multipotent stem cells with characteristics similar to bone marrowderived mesenchymal stem cells (BMSCs), easier to isolate and effective in wound healing enhancement.
Each patient being considered for stem cells graft was subjected to a conventional liposuction procedure (local anaesthesia, aspirated volume about 80cc), in order to isolate a pellet of adipose-derived stem cells (ASCs), which was then mixed with the platelet-rich plasma (PRP) previously collected, in order to obtain an enhanced-ASCs- PRP (e-PRP), now ready for grafting in the context of skin edges as well as at the bottom of the lesion itself.
Flow cytometric analysis performed on the pellet obtained with our isolation process, showed that a mean of 5 x 105 ASCs (range: 4,0-6,0 x 105, SD: ± 1 x 105) were collected from 80 ml of adipose tissue, harvested with standard wet liposuction procedure. It represented the 5% of all sample cells (1 x 107), while the others 95% were mostly being blood-derived and endothelial cells.
By now, the most used isolation protocols take about two hours due to the complex isolation procedure, requiring both animal-derived reagents and collagenase. The amount of ASCs obtained with our isolation process is sufficient to be directly engrafted in the wound without the need of in vitro expansion but, neither serum nor animalderived reagents are used, and it takes only 15' minutes.
ASCs application is an innovative, effective approach in the treatment of chronic wounds.
脂肪组织是多能干细胞的另一个来源,其特性与骨髓间充质干细胞(BMSCs)相似,易于分离且在促进伤口愈合方面有效。
每一位考虑进行干细胞移植的患者都要接受传统的吸脂手术(局部麻醉,吸脂量约80cc),以分离出脂肪源性干细胞(ASCs)沉淀,然后将其与先前采集的富血小板血浆(PRP)混合,以获得增强型ASCs-PRP(e-PRP),现在可用于在皮肤边缘以及病变底部进行移植。
对通过我们的分离过程获得的沉淀进行流式细胞术分析表明,从80毫升脂肪组织中平均收集到5×10⁵个ASCs(范围:4.0 - 6.0×10⁵,标准差:±1×10⁵),这些脂肪组织是通过标准湿式吸脂手术采集的。它占所有样本细胞(1×10⁷)的5%,而其他95%主要是血液来源的细胞和内皮细胞。
到目前为止,由于分离过程复杂,需要动物源性试剂和胶原酶,最常用的分离方案大约需要两个小时。通过我们的分离过程获得的ASCs数量足以直接移植到伤口中,无需体外扩增,而且既不使用血清也不使用动物源性试剂,整个过程仅需15分钟。
ASCs的应用是治疗慢性伤口的一种创新且有效的方法。